Jump to content

Drug vectorization

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Kku (talk | contribs) at 17:06, 28 January 2016 (→top: not necessarily intra). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

In pharmacology and medicine vectorization of drugs refers to (intracellular) targeting with plastic or silicon nanoparticles or liposomes to which pharmacologically active substances are reversibly bound or attached by adsorption.[1][2]

CNRS researchers have devised a way to overcome the problem of multidrug resistance using polyalkylcyanoacrylate (PACA) nanoparticles as "vectors".[3]

References

  1. ^ Couvreur P. (2001). "Drug vectorization or how to modulate tissular and cellular distribution of biologically active compounds". Ann Pharm Fr. 59 (4): 232–8. PMID 11468577.
  2. ^ {{"Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs". Adv Healthc Mater. 2 (5): 718–27. 2013. doi:10.1002/adhm.201200335. PMID 23203914.
  3. ^ http://www.cnrs.fr/Cnrspresse/en380a6.htm

This article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Drug_vectorization&oldid=702130483"